In breast cancer, it has been found that MSCs inhibit FoxP2 by increasing the expression of mir-214 and mir-199 in these cancer cells, thus increasing the growth, metastasis, and staying in the phenotypic state of cancer stem cells (153). The gene discussed is FOXP2; the disease is cancer.